H Ouyang Selected Research

H Ouyang Research Topics

6	Neoplasms (Cancer) 02/2021 - 04/2000
4	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 04/2000
2	Hepatocellular Carcinoma (Hepatoma) 05/2022 - 10/2015
2	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 11/2021 - 10/2004
2	Rectal Neoplasms (Rectal Cancer) 02/2021 - 02/2016
2	Atherosclerosis 01/2018 - 12/2014
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2017 - 09/2014
2	Carcinoma (Carcinomatosis) 02/2016 - 04/2000
1	Allergic Rhinitis 11/2021
1	Lymphatic Metastasis 02/2021
1	Osteoarthritis 01/2020
1	Vascular Diseases (Vascular Disease) 01/2018
1	Mobility Limitation (Difficulty Walking) 01/2018
1	Breast Neoplasms (Breast Cancer) 05/2017
1	Alzheimer Disease (Alzheimer's Disease) 06/2016
1	Abscess 04/2016
1	Esophageal Perforation 04/2016
1	Foreign Bodies (Foreign Body) 04/2016
1	Infections 04/2016
1	Squamous Cell Carcinoma of Head and Neck 01/2016
1	Carcinogenesis 10/2015
1	Hemorrhage 12/2014
1	Bernard-Soulier Syndrome (Giant Platelet Syndrome) 12/2014
1	Prostatic Neoplasms (Prostate Cancer) 11/2014
1	Neoplasm Metastasis (Metastasis) 09/2014
1	Fibrosis (Cirrhosis) 10/2011
1	Hypertrophy 10/2011
1	Adenocarcinoma 06/2011
1	Bone Resorption 10/2001
1	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2001
1	Microsatellite Instability 04/2000

4	Biomarkers (Surrogate Marker)IBA 02/2021 - 10/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 01/2018
2	Epidermal Growth Factor (EGF)IBA 01/2017 - 09/2014
1	Peptides (Polypeptides)IBA 11/2021
1	Therapeutic UsesIBA 11/2021
1	AllergensIBA 11/2021
1	Nik related kinaseIBA 01/2020
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2018
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2018
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2018
1	Testosterone (Sustanon)FDA Link 01/2018
1	GelsIBA 01/2018
1	Monoclonal AntibodiesIBA 01/2018
1	Leucovorin (Folinic Acid)FDA Link 01/2018
1	Vascular Endothelial Growth Factor CIBA 01/2018
1	Vascular Endothelial Growth Factor DIBA 01/2018
1	RamucirumabIBA 01/2018
1	auraptenIBA 06/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2016
1	ErbB Receptors (EGF Receptor)IBA 01/2016
1	Biological ProductsIBA 01/2016
1	Long Noncoding RNAIBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	Cetuximab (Erbitux)FDA Link 01/2016
1	CateninsIBA 10/2015
1	Sorafenib (BAY 43-9006)FDA Link 10/2015
1	LigandsIBA 12/2014
1	Platelet Membrane GlycoproteinsIBA 12/2014
1	Glycoproteins (Glycoprotein)IBA 12/2014
1	oxidized low density lipoproteinIBA 12/2014
1	MyostatinIBA 10/2011
1	AntigensIBA 06/2011
1	Opioid Analgesics (Opioids)IBA 06/2011
1	CalciumIBA 10/2001
1	zhuhuangIBA 04/2001
1	DNA (Deoxyribonucleic Acid)IBA 04/2000

3	Drug Therapy (Chemotherapy) 11/2021 - 06/2011
2	Therapeutics 01/2018 - 01/2016
1	Hepatectomy 05/2022
1	Neoadjuvant Therapy 05/2017
1	Nutritional Support (Artificial Feeding) 04/2016
1	General Anesthesia 04/2016
1	Esophagoscopes 04/2016
1	Chemoradiotherapy 02/2016
1	Radiotherapy 11/2014
1	Analgesia 06/2011
1	Complementary Therapies (Alternative Medicine) 10/2004